Conversion From Twice-Daily Tacrolimus to Once-Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial

by Bunnapradist, S, Ciechanowski, K, West-Thielke, P, Mulgaonkar, S, Rostaing, L, Vasudev, B, Budde, K
Published 2013

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients

by Gaber, A. Osama, Alloway, Rita R., Bodziak, Kenneth, Kaplan, Bruce, Bunnapradist, Suphamai
Published 2013

Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS

by Chan, Laurence, Andres, Amado, Bunnapradist, Suphamai, Gugliuzza, Kristene, Parasuraman, Ravi, Peddi, V. Ram, Cassuto, Elisabeth, Hart, Marquis
Published 2012

Cardiorenal syndrome and vitamin D receptor activation in chronic kidney disease☆

by Darabian, Sirous, Rattanasompattikul, Manoch, Hatamizadeh, Parta, Bunnapradist, Suphamai, Budoff, Matthew J., Kovesdy, Csaba P., Kalantar-Zadeh, Kamyar
Published 2012

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients

by Stanley C. Jordan, MD, FASN, FAST, Suphamai Bunnapradist, MD, Jonathan S. Bromberg, MD, PhD, Anthony J. Langone, MD, David Hiller, PhD, James P. Yee, MD, PhD, John J. Sninsky, PhD, Robert N. Woodward, PhD, Arthur J. Matas, MD
Published 2018-09-01